- Article metrics
- Last updated: Fri, 19 Apr 2024 22:45:16 Z
Implications to payers of switch from hospital-based intravenous immunoglobulin (IVIg) to home-based subcutaneous immunoglobulin (SCIg) therapy in patients with primary immunodeficiencies (PID) and secondary immunodeficiencies (SID) in Canada
Access & Citations
-
- 1663
- Article Accesses
-
- 0
- Web of Science
-
- 0
- CrossRef
Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.